The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this huge ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor.

A group of clinicians and patients has called on the government at Holyrood to adopt a “Scotland-wide focus” on chronic kidney disease (CKD), saying that as many as 600,000 Scots are now thought to be ...

AstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance ...

Analyst Etzer Darout of BMO Capital maintained a Buy rating on AstraZeneca (AZN – Research Report), retaining the price target of $89.00.

AstraZeneca (GB:AZN) has released an update. AstraZeneca remains committed to delivering its innovative medicines in China despite ongoing ...

AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...

AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior ...

(In 2020, Alexion was bought by AstraZeneca for $39 billion.) “The thing that stood out from our time at Alexion was that ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

The study was funded by UCB. Zouboulis declared relationships with AstraZeneca, Boehringer Ingelheim, Brandenburg Medical ...